Evidence map›Paper›PMID 34444739›Full record

Trial reportNutrients2021

Effect of Wholegrain Flour Particle Size in Bread on Glycaemic and Insulinaemic Response among People with Risk Factors for Type 2 Diabetes: A Randomised Crossover Trial.

Evelyn Mete, Jillian Haszard, Tracy Perry, Indrawati Oey, Jim Mann, Lisa Te Morenga

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Evelyn MeteDepartment of Human Nutrition, University of Otago, Dunedin 9054, New Zealand.
Jillian HaszardDepartment of Human Nutrition, University of Otago, Dunedin 9054, New Zealand.ORCID 0000-0001-6312-7795
Tracy PerryDivision of Sciences, University of Otago, Dunedin 9054, New Zealand.
Indrawati OeyDepartment of Food Science, University of Otago, Dunedin 9054, New Zealand.ORCID 0000-0001-9966-0495
Jim MannDepartment of Human Nutrition, University of Otago, Dunedin 9054, New Zealand.
Lisa Te MorengaRiddet Institute, Palmerston North 4442, New Zealand.

Funding

Healthier Lives National Science Challenge N/ARiddet Centre of Research Excellence New Zealand N/ARoyal Society of New Zealand Rutherford Discovery Fellowship N/A
6 · The paper itself

Abstract

Wholegrain flour produced by roller-milling is predominantly comprised of fine particles, while stoneground flour tends to have a comparatively smaller proportion of fine particles. Differences in flour particle size distribution can affect postprandial glycaemia in people with type 2 diabetes and postprandial insulinaemia in people with and without type 2 diabetes. No prior studies have investigated the effect of wholegrain flour particle size distribution on glycaemic or insulinaemic response among people with impaired glucose tolerance or risk factors for type 2 diabetes. In a randomised crossover study, we tested the 180-min acute glycaemic and insulinaemic responses to three wholegrain breads differing in flour particle size and milling method: (1) fine roller-milled flour, (2) fine stoneground flour, and (3) coarse stoneground flour. Participants (

Indexed as

BreadFlourWhole GrainsAgedBlood GlucoseCross-Over StudiesDiabetes Mellitus, Type 2FemaleGlucose IntoleranceHumansInsulinMaleMealsMiddle AgedParticle SizePostprandial PeriodBlood GlucoseInsulinacute blood glucosedigestionglycaemiagrain particle sizeinsulinmetabolismstoneground flourstone-milled flourwhole grainwholegrain flour

Identifiers

PMID34444739
PMCPMC8398996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.